Dyskinesia in Parkinson's Disease (Study P04501)

Clinical trial NCT00406029 · COMPLETED

Trial details

NCT number: NCT00406029
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease Movement Disorders Central Nervous System Diseases Neurodegenerative Diseases Brain Diseases

Start date: 2006-11-20
Primary completion: 2008-10-05
Enrollment: 253

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.